Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,055.0
-68.2 (-2.18%)

 

  • STI Straits Times Index
    3,055.0
    -68.2 (-2.18%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,582.5
    4.9 (0.31%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,027.6
    308.9 (1.11%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,490.4
    60.8 (1.77%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,084.5
    636.5 (2.32%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,975.8
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 3,365.6M
  • Value: 3,210.3M
  • Rise: 58
  • Fall: 386
  • Unch: 328

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Shen Yao0.007-0.002
Sembcorp Marine0.179-0.012
Oceanus^0.033-0.003
Genting Sing0.785-0.025
YZJ Shipbldg SGD1.410-0.050
Golden Agri-Res0.250-0.025
Singtel2.320-0.090
Frasers Property1.160-0.040
ThaiBev0.670-0.025
Jiutian Chemical0.091-0.007

World Indices

World Indices
Name Last Change
Nasdaq 13,430.0 +305.0
HSI 28,027.6 +308.9
HSCEI 10,405.0 +65.0
Jakarta 5,975.8
Nikkei 225 28,084.5 +636.5
SSE Comp 3,490.4 +60.8
Shanghai A 3,658.5 +63.8
Shanghai B 250.2 +2.5
KOSPI 3,153.3 +31.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SELLAS LIFE SCIENCES GROUP INC SELLAS LIFE SCIENCES GROUP
Updated on 14 May 2021 (End of trading day)
Last (USD): 8.150 Change: +0.540 High: 8.500 Remarks: -
Change (%): +7.10 Low: 7.890
Open 8.130 Yesterday's Close 7.61
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 305,392 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.11602 Trailing EPS (USD) e -1.11602 NAV (USD) b -
PE a - Trailing PE f - Price / NAV b -
Dividend (USD) d - Cash In Hand (USD) g 1.8650 Issued & Paid-up Shares c 15,084,800
Dividend Yield (%) d - Price / Cash In Hand g 4.370 Treasury Shares h -
Market Cap (M) 122.941 Enterprise Value (M) 95.757
Piotroski F Score 1 Exchange Code SLS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 120.77 Free Float (%) 98.6
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 24 Mar 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 02 Jan 2018.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SELLAS LIFE SCIENCES GROUP INC NASDAQ 122.941 - - - -
Industry Biotechnology NASDAQ 2,873.271 106.306 106.381 6.4435 0.614
Local Peer AMGEN INC NASDAQ 144,431.385 19.883 20.386 15.4737 2.563
Local Peer GILEAD SCIENCES INC NASDAQ 85,948.955 698.787 285.545 4.5351 3.968
Local Peer MODERNA INC NASDAQ 64,798.589 - 108.329 16.8834 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 56,197.220 20.724 20.346 6.2579 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 55,042.746 15.667 13.748 4.5957 -
Local Peer ILLUMINA INC NASDAQ 55,630.380 84.802 88.302 11.3024 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 46,558.003 2,687.439 32.032 15.7222 -
Local Peer BIOGEN INC NASDAQ 42,187.017 10.545 14.008 3.9493 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 38,344.586 63.548 56.240 3.0881 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 29,339.111 - - 7.3280 -
Local Peer SEAGEN INC NASDAQ 26,767.857 43.619 40.517 7.8163 -
Local Peer INCYTE CORPORATION NASDAQ 18,170.038 - 37.974 6.6610 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), NOVAVAX INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), EXELIXIS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), ALKERMES PLC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), ARVINAS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), XENCOR INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), INSTIL BIO INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), FIBROGEN INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), SEER INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), MACROGENICS INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), OCUGEN INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), BIOATLA INC (NASDAQ), REGENXBIO INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), ALLOVIR INC (NASDAQ), IMMUNOVANT INC (NASDAQ), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), PRECIGEN INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), IMMUNOGEN INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), SHATTUCK LABS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), CORTEXYME INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), HUMANIGEN INC (NASDAQ), VAXCYTE INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), RADIUS HEALTH INC (NASDAQ), EPIZYME INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), MERUS B V (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PERSONALIS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), NKARTA INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ANAPTYSBIO INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CHEMOCENTRYX INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), AGENUS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ATHIRA PHARMA INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), IMMATICS N V (NASDAQ), ARDELYX INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), INHIBRX INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), KADMON HLDGS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), IVERIC BIO INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), XBIOTECH INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), VERASTEM INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), ALTIMMUNE INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), AKOUOS INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ADICET BIO INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SESEN BIO INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), ONCORUS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), XOMA CORP (NASDAQ), ATRECA INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), KAMADA LTD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CHIASMA INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), MEDICINOVA INC (NASDAQ), IMMUNOME INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), BIOVIE INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), EQUILLIUM INC (NASDAQ), IMV INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CONTRAFECT CORP (NASDAQ), INMUNE BIO INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), EVOGENE LTD (NASDAQ), GLYCOMIMETICS INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), INFLARX N V (NASDAQ), OTONOMY INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), RECRO PHARMA INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), LONGEVERON INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), METACRINE INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), AIKIDO PHARMA INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), COHBAR INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), PRECIPIO INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ATYR PHARMA INC (NASDAQ), VACCINEX INC (NASDAQ), BIOCARDIA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ADVAXIS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), SOLIGENIX INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), PALISADE BIO INC (NASDAQ), HISTOGEN INC (NASDAQ), GEOVAX LABS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer AMGEN-T HKEx 1,011,789.594 17.959 18.421 13.9429 2.837
Global Peer CSL LTD ASX 126,377.722 40.295 33.207 11.9593 1.057
Global Peer WUXI BIO HKEx 439,596.059 231.634 231.636 18.0296 -
Global Peer BEIGENE HKEx 223,038.984 - - 7.1658 -
Global Peer SINO BIOPHARM HKEx 159,450.856 51.206 51.207 8.0306 0.864
Global Peer ZAI LAB-SB HKEx 110,970.468 - - 12.2390 -
Global Peer GENSCRIPT BIO HKEx 46,614.076 - - 6.6670 -
Global Peer JOINN HKEx 37,589.899 106.193 83.266 4.8040 0.237
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer KINTOR PHARMA-B HKEx 25,171.315 - - 14.0791 -
Other Global Peers 3SBIO (HKEx), NUVATION BIO INC (NYSE), ALPHAMAB-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), JACOBIO-B (HKEx), MYOVANT SCIENCES LTD (NYSE), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), ASCENTAGE-B (HKEx), JW THERAP-B (HKEx), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), IMUGENE LIMITED (ASX), JHBP-B (HKEx), MESOBLAST LTD (ASX), TELIX PHARMACEUTIC (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), DPHARMA (Bursa), ASCLETIS-B (HKEx), ANTEOTECH LIMITED (ASX), SINOMAB BIO-B (HKEx), 22ND CENTURY GROUP INC (NYSE American), ESSEX BIO-TECH (HKEx), OPTHEA LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), LEE'S PHARM (HKEx), SQZ BIOTECHNOLOGIES CO (NYSE), NEXT SCIENCE LTD (ASX), IMMUTEP LTD (ASX), NANOVIRICIDES INC (NYSE American), CEL-SCI CORP (NYSE American), BIONOMICS LTD (ASX), ENZO BIOCHEM INC (NYSE), IBIO INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), BIOMX INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), LEAF RESOURCES LTD (ASX), UNI-BIO GROUP (HKEx), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), CHIMERIC THERAPEUTICS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), GENETIC TECHNOLOGIES (ASX), REGENT PACIFIC (HKEx), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), PRESCIENT THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), CONTANGO ASSET MANAGEMENT LIMITED (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), MEMPHASYS LTD (ASX), Suntar Eco-City (SGX), RHINOMED LIMITED (ASX), PATRYS LIMITED (ASX), ORAGENICS INC (NYSE American), BIOTRON (ASX), BIOSINO BIO-TEC (HKEx), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ADALTA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), REGENEUS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), CRYOSITE (ASX), HOLISTA COLLTECH LIMITED (ASX), NANOLLOSE LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), ANATARA LIFESCIENCES LTD (ASX), HAO WEN HLDGS (HKEx), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.080
+0.99 %
10 Days -+0.270
+3.43 %
20 Days -+0.610
+8.09 %
Medium Term Return 3 Months --1.290
-13.67 %
6 Months -+5.520
+209.89 %
1 Year -+5.290
+184.97 %
Long Term Return 2 Years --31.850
-79.62 %
3 Years --270.850
-97.08 %
Annualised Return Annualised --
-69.20 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.760 - 19.380 Change From 1 Year Low +6.390 % Change From 1 Year Low (%) +363.07
Change From 1 Year High -11.230 % Change From 1 Year High (%) -57.95
2 Years Range 1.455 - 42.195 Change From 2 Years Low +6.695 % Change From 2 Years Low (%) +460.14
Change From 2 Years High -34.045 % Change From 2 Years High (%) -80.68
5 Years Range 1.455 - 554.500 Change From 5 Years Low +6.695 % Change From 5 Years Low (%) +460.14
Change From 5 Years High -546.350 % Change From 5 Years High (%) -98.53
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company. It engages in the development and commercialization of immunotherapeutic for cancer indications. The firm's product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Historical Price Data

Date Open High Low Close Volume VWAP